1.
Sajad Q, Khan KA, Iqbal J, Khan AZ, Khan D, Mustafa MI. Beyond Glucose: Empagliflozin’s Impact on Fatty Liver in Patients with Type 2 Diabetes; A True Game Changer. IJBR [Internet]. 2025 Feb. 17 [cited 2026 Feb. 26];3(2):193-8. Available from: https://ijbr.com.pk/IJBR/article/view/663